Pat Yang Archives - Executive Platforms: Thought Leader Series

Panel Discussion: Reflecting on the Past, Envisioning the Future: Shaping the New Landscape of Biomanufacturing

December 2, 2024

Assessing Changes in the CMC Ecosystem: Are We Overbuilding Capacity Again?
Uniting for Success: Strategies to Prevent Fragmentation and Foster Collaboration in Biomanufacturing
Pioneering New Ventures: Reasons to Establish a New Company Today and Anticipating Future Growth in the Business Ecosystem
Evaluating Production Platforms for Emerging Modalities: Which Platforms Will Best Serve the Future of Medicine?
Navigating the Future of Existing Platforms: Efficiently Addressing Market Needs for Established Therapies such as mAbs, ADCs, and mRNA-based Treatments

LIFE SCIENCES, VIDEO, LIFE SCIENCES

Panel: Looking Backwards, Looking Forwards: Maximizing Our Impact on the Future of Medicine

May 28, 2024

How has this changed the CMC ecosystem, and are we overbuilding capacity again?
Avoiding the dangers of fragmentation. How should we better communicate, collaborate, and consolidate our best ideas so we all succeed?
Discussing the reasons to set up a new company today, and imagining how our business ecosystem will continue to grow and evolve
Debating which production platforms will best suit the newer modalities
Exploring the next steps for existing platforms like mAbs, ADC’s, mRNA: How do we efficiently serve giant markets such as Alzheimer’s indications, for example?

LIFE SCIENCES, VIDEO, LIFE SCIENCES

Panel: Biotech Manufacturing Industrialization, Talent Development, and Leadership — A Tribute to Our Friend Mike Kamarck

November 22, 2023

This panel discussion, presented in memoriam of Dr. Michael Kamarck, reflects on the last few decades of the industrialization of biologics manufacturing and what the future may hold.

LIFE SCIENCES, VIDEO, LIFE SCIENCES

Panel: ‘Next’ Generation Manufacturing: What Did We Learn and Where Are We Going?

May 25, 2023

At PMWS23 we recorded a panel on ‘Next’ Generation Manufacturing that looks at where the industry has come from, and where it’s going in the future.

From discussing how today’s pipeline and technologies are reshaping biomanufacturing, to looking at the technologies that enable next generation manufacturing processes, give this one a listen!

LIFE SCIENCES, VIDEO, LIFE SCIENCES

Panel: Looking Backwards, Looking Forwards: Maximizing Our Impact on the Future of Medicine

November 28, 2022

The past few years has seen a migration of talent and technology from traditional biopharmaceutical manufacturing to ATMP manufacturing: How has this changed the CMC ecosystem, and are we overbuilding capacity again? Avoiding the dangers of fragmentation. How should we better communicate, collaborate, and consolidate our best ideas so we all succeed? Discussing the reasons to set up a new company today, and imagining how our business ecosystem will continue to grow and evolve Debating which production platforms will best suit the newer modalities Exploring the next steps for existing platforms like mAbs: How do we efficiently serve giant markets…

LIFE SCIENCES, VIDEO, LIFE SCIENCES

Panel: Looking at the Big Picture: Where is Our Industry Going, and How Should We Get There?

December 1, 2020

Debating the merits of nimble and flexible facilities versus manufacturing battleships Preparing your pilot plants and manufacturing facilities to move forward with Phase II-III approvals Forecasting requirements for optimizing manufacturing equipment, facilities and partners to increase speed to market Achieving business goals to better manage times of product and economic uncertainty Putting theory into practice: Implementing key metrics to improve manufacturing flexibility — Moderators: Pat Yang Chairman at Acepodia & Founding Board Director at Sana Biotechnology Dr. Patrick Y. Yang has over 35 years leadership experience in technology, manufacturing, supply chain, and operational management functions in General Electric, Merck, Genentech,…

LIFE SCIENCES, VIDEO, LIFE SCIENCES

BMWS20 – Opening Chairs’ Remarks and Keynote: Reinventing a Biopharma Company for the 21st Century

December 1, 2020

Bristol Myers Squibb is a company that has undergone an extensive transformation and as a result, has reinvented itself Once a company consisting of multiple and vastly different business units, it is now the largest diversified specialty global biopharma company Its mission and focus is to utilize innovation to advance the treatment of serious disease and significant unmet medical need This organizational evolution required substantial change for the product development and manufacturing arms of the company Technology, systems, processes, people and culture all needed to be re-evaluated through a “new lens” The presentation will cover this journey including approach, successes,…

LIFE SCIENCES

Panel: Staying Ahead of the Curve in the Increasingly Complex Regulatory World of Cell and Gene Therapy

November 26, 2019

Discussing the growing regulatory complexity in the world of pharmaceutical manufacturing. How are new guidelines and regulators’ expectations during inspections changing? Taking a process-based approach to impact assessment, and customizing a setup that identifies and acts on signals proactively Bringing a structured approach to your advocacy within your network of industry and trade organization connections Embracing the idea that keeping things simple even in a complex environment generates the best outcomes — Pat Yang Former EVP at Juno Therapeutics, Roche and Genentech Dr. Patrick Y. Yang has over 35 years leadership experience in technology, manufacturing, supply chain, and operational management…

Pat Yang

Panel Discussion: Reflecting on the Past, Envisioning the Future: Shaping the New Landscape of Biomanufacturing

Panel: Looking Backwards, Looking Forwards: Maximizing Our Impact on the Future of Medicine

Panel: Biotech Manufacturing Industrialization, Talent Development, and Leadership — A Tribute to Our Friend Mike Kamarck

Panel: ‘Next’ Generation Manufacturing: What Did We Learn and Where Are We Going?

Panel: Looking Backwards, Looking Forwards: Maximizing Our Impact on the Future of Medicine

Panel: Looking at the Big Picture: Where is Our Industry Going, and How Should We Get There?

BMWS20 – Opening Chairs’ Remarks and Keynote: Reinventing a Biopharma Company for the 21st Century

Panel: Staying Ahead of the Curve in the Increasingly Complex Regulatory World of Cell and Gene Therapy

NASCES

NAFS

NAFMS

EUSCES

BMWS

NALES

MDMES

NAFES

NASRS

NAHRES

NAMES

PMWS

NAISS

Categories

Newsletter